This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

 Previous Article  |  Next Article 

WASHINGTON UPDATE

Reye Syndrome and labels

A House subcommittee voted last month to require labels on aspirin bottles warning that use of the pain reliever might increase a child's risk of developing Reye Syndrome.

The Health Subcommittee of the House Energy and Commerce Committee adopted the provision despite claims by the Reagan Administration that voluntary labeling efforts by aspirin makers is working.

The U.S. Food and Drug Administration reports that 58 percent of the children's aspirin on store shelves in early October featured warning labels. Most of those labels did not mention Reye Syndrome by name, but did advise parents to call a physician before giving aspirin to children or teenagers with flu.